Alkanhal Abdulrahman, Ducas Robin, Mackie Andrew S, Seaman Cameron, Averin Konstantin, Mah Kandice, Khoury Michael
Division of Cardiology, Department of Pediatrics, Stollery Children's Hospital, University of Alberta, 8440-112th St. NW, Edmonton, AB, T6G 2B7, Canada.
Department of Cardiac Sciences, King Saud University, Riyadh, Saudi Arabia.
Pediatr Cardiol. 2023 Apr;44(4):845-854. doi: 10.1007/s00246-022-03073-x. Epub 2022 Dec 20.
Indications for the closure of pressure restrictive perimembranous ventricular septal defects (pmVSD) are not well established in the pediatric population. We sought to assess practice variability among pediatric cardiologists in the United States (US), Canada, Australia, and New Zealand. A survey ascertaining practice patterns, including case vignettes with incremental progression of disease severity, was designed and administered through representative professional cardiac organizations and email listservs in the designated countries. Among the 299 respondents, 209 (70.0%) were from the US, 65 (21.7%) were from Canada and 25 (8.3%) were from Australia and New Zealand. Indications for pressure restrictive pmVSD closure included the presence of left ventricular (LV) dilation for 81.6% (244/299) (defined as z-score ≥ 2 for 59.0% (144/244) and ≥ 3 for 40.2% (98/244)) and significant pulmonary-systemic flow ratio (QP:QS) for 71.2% (213/299) [defined as ≥ 1.5:1 for 36.2% (77/213) and ≥ 2 for 62% (132/213)]. US pediatric cardiologists elected to close restrictive pmVSD at lower LV z-score and QP:QS ratio cut-offs (p-value 0.0002 and 0.013, respectively). In a case vignette, 63.6% (173/272) chose to intervene if there was right coronary cusp prolapse with stable mild aortic regurgitation. Of the remaining cardiologists, 93% (92/99) intervened if the aortic regurgitation was progressive (from trivial to mild). Commonly identified indications with variable thresholds for closure of pressure restrictive pmVSDs included the presence or progression of LV dilation, significant volume loading, and aortic valve prolapse with regurgitation. US pediatric cardiologists may have a lower threshold for pmVSD closure.
在儿科人群中,压力限制性膜周部室间隔缺损(pmVSD)封堵术的适应证尚未明确。我们试图评估美国、加拿大、澳大利亚和新西兰儿科心脏病专家的临床实践差异。通过指定国家的代表性专业心脏组织和电子邮件列表,设计并实施了一项调查,以确定临床实践模式,包括疾病严重程度逐步增加的病例 vignette。在299名受访者中,209名(70.0%)来自美国,65名(21.7%)来自加拿大,25名(8.3%)来自澳大利亚和新西兰。压力限制性pmVSD封堵术的适应证包括左心室(LV)扩张,占81.6%(244/299)(59.0%(144/244)定义为z评分≥2,40.2%(98/244)定义为≥3),以及显著肺循环与体循环血流比(QP:QS),占71.2%(213/299)[36.2%(77/213)定义为≥1.5:1,62%(132/213)定义为≥2]。美国儿科心脏病专家选择在较低LV z评分和QP:QS比值阈值时关闭限制性pmVSD(p值分别为0.0002和0.013)。在一个病例 vignette 中,如果右冠状动脉瓣叶脱垂伴稳定轻度主动脉瓣反流,则63.6%(173/272)选择干预。在其余心脏病专家中,如果主动脉瓣反流进展(从微量到轻度)则93%(92/99)选择干预。压力限制性pmVSD封堵术常见确定的适应证及不同关闭阈值包括LV扩张的存在或进展、显著容量负荷以及伴反流的主动脉瓣脱垂。美国儿科心脏病专家对pmVSD封堵术的阈值可能较低。